Study Information
Status: Active, Recruiting
Study Details
View study details on clinicaltrials.gov.
Locations
Santa Rosa, Solano/Vallejo, San Francisco, Greater Sacramento Valley, San Mateo, East Bay, Modesto, Palo Alto/Santa Cruz
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
S1900K (LUNG-MAP SUB-STUDY): A Randomized Phase II Study of Tepotinib With or Without Ramucirumab in Participants With MET Exon 14 Skipping Positive Stage IV or Recurrent Non-Small Cell Lung Cancer
Principal Investigator
Related Studies
The Impact of Smoking, Comorbidities, and Race/Ethnicity on COVID-19 Infection and Disease Severity
Using EHR from a large healthcare system in Northern CA, we will study the impact of smoking, comorbidities, race on COVID-19 infection and disease severity.
Investigator: Jiang Li, Ph.D., MPH